Ethical Considerations in Standardized Letters of Evaluation for Dermatology Residency Selection

The introduction of dermatology's specialty-specific Standardized Letter of Evaluation (SLOE) for the 2026-2027 residency cycle aims to improve fairness, comparability, and reduce bias in applicant assessment. Although standardization may reduce differences in writing style and interpretation, it does not eliminate subjectivity and may redistribute how and where bias affects the process. Rating inflation, ceiling effects, and interrater variability have been reported in dermatology and other specialties, while evidence that standardized ratings predict residency performance remains limited; furthermore, standardizing evaluation does not standardize opportunity: ratings of research, professionalism, and communication may reflect differences in mentorship, resources, clinical exposure, and evaluator relationships. Programs should, therefore, avoid interpreting small numerical differences as precise measures of ability and instead consider SLOEs within a holistic review. Ethical implementation will require ongoing assessment of rating inflation, interrater variability, demographic disparities, and predictive validity. Ultimately, the SLOE's value will depend on whether it improves comparability and transparency without creating false precision or masking unequal opportunities.